Correlation Between Cardiff Oncology and Coya Therapeutics,
Can any of the company-specific risk be diversified away by investing in both Cardiff Oncology and Coya Therapeutics, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cardiff Oncology and Coya Therapeutics, into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Cardiff Oncology and Coya Therapeutics, Common, you can compare the effects of market volatilities on Cardiff Oncology and Coya Therapeutics, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cardiff Oncology with a short position of Coya Therapeutics,. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cardiff Oncology and Coya Therapeutics,.
Diversification Opportunities for Cardiff Oncology and Coya Therapeutics,
0.37 | Correlation Coefficient |
Weak diversification
The 3 months correlation between Cardiff and Coya is 0.37. Overlapping area represents the amount of risk that can be diversified away by holding Cardiff Oncology and Coya Therapeutics, Common in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Coya Therapeutics, Common and Cardiff Oncology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cardiff Oncology are associated (or correlated) with Coya Therapeutics,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Coya Therapeutics, Common has no effect on the direction of Cardiff Oncology i.e., Cardiff Oncology and Coya Therapeutics, go up and down completely randomly.
Pair Corralation between Cardiff Oncology and Coya Therapeutics,
Given the investment horizon of 90 days Cardiff Oncology is expected to generate 1.34 times more return on investment than Coya Therapeutics,. However, Cardiff Oncology is 1.34 times more volatile than Coya Therapeutics, Common. It trades about 0.05 of its potential returns per unit of risk. Coya Therapeutics, Common is currently generating about 0.04 per unit of risk. If you would invest 132.00 in Cardiff Oncology on September 6, 2024 and sell it today you would earn a total of 109.00 from holding Cardiff Oncology or generate 82.58% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Very Weak |
Accuracy | 98.38% |
Values | Daily Returns |
Cardiff Oncology vs. Coya Therapeutics, Common
Performance |
Timeline |
Cardiff Oncology |
Coya Therapeutics, Common |
Cardiff Oncology and Coya Therapeutics, Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Cardiff Oncology and Coya Therapeutics,
The main advantage of trading using opposite Cardiff Oncology and Coya Therapeutics, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cardiff Oncology position performs unexpectedly, Coya Therapeutics, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Coya Therapeutics, will offset losses from the drop in Coya Therapeutics,'s long position.Cardiff Oncology vs. Reviva Pharmaceuticals Holdings | Cardiff Oncology vs. PDS Biotechnology Corp | Cardiff Oncology vs. Reviva Pharmaceuticals Holdings | Cardiff Oncology vs. Eyenovia |
Coya Therapeutics, vs. Cue Biopharma | Coya Therapeutics, vs. Lantern Pharma | Coya Therapeutics, vs. Fennec Pharmaceuticals | Coya Therapeutics, vs. Eliem Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.
Other Complementary Tools
Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities |